Goldpoint Clinical Research is a clinical research site located in Indianapolis, Indiana, United States 46260.
Crixeo Clinical Trials Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Goldpoint Clinical Research has participated in 10 clinical trials.
Therapeutic areas: Insomnia, Attention Deficit Hyperactivity Disorder, Excessive Sleepiness.
Sponsors: Sumitomo Pharma America, Inc., Cephalon, Mallinckrodt.
Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Goldpoint Clinical Research has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Goldpoint Clinical Research has 10 clinical trials on record. Their work covers Insomnia, Attention Deficit Hyperactivity Disorder, Excessive Sleepiness.
Goldpoint Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.